EUVIMEDEUVIMED entdecken
Crossref

An Updated Comprehensive Review of the Dengue Vaccine: Development, Mechanism, Efficacy, and Safety

Manoj Ramesh Kumbhare, Siddhi M. Chandak, Aishwarya Balasaheb Dukare, Vaibhavi Vijay Kshatriya, Sakshi S. Velhal

Journal of Bio-X Research · 2025-01 · 8

DOI: 10.34133/jbioxresearch.0034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Bio-X Research, online erschienen am 19.03.2025. Verfasst von Manoj Ramesh Kumbhare und 4 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 75 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dengue virus (DENV) is spread through bites from mosquitos of the Aedes genus. DENV activates antibodies against 4 dengue serotypes, which are identified by the plaque reduction neutralization test of 50%, and the dengue antivirals use nonstructural viral antigens to excite T cells. Dengue vaccines include a live attenuated vaccine, inactivated vaccine, and DNA vaccine, among others. DENV is via dengue enzyme-linked immunosorbent assay (ELISA)-immunoglobulin (Ig). In 2009, the World Health Organization classified patients with DENV according to clinical presentation (dengue fever with rash, headache, eye pain, muscular pain, joint pain, and leukopenia) and positive test results for nonstructural protein 1 and dengue IgM antibodies by ELISA. The Dengvaxia vaccine is in second phase III trials; it was released by Sanofi Pasteur for use in Mexico in 2015 and was being used in more than 20 countries by 2017. After 30 years of research, only the live attenuated vaccine has passed phase III trials. Clinical trials for treating infections with Flavivirus viruses have been conducted in Asia and North and South America. Phase I to phase III trials involving 40,000 volunteers from 16 countries have assessed the vaccine safety, immunogenicity, and protection.

Zitieren

APA

Kumbhare, M. R., Chandak, S. M., Dukare, A. B., Kshatriya, V. V., & Velhal, S. S. (2025). An Updated Comprehensive Review of the Dengue Vaccine: Development, Mechanism, Efficacy, and Safety. Journal of Bio-X Research, 8. https://doi.org/10.34133/jbioxresearch.0034

Vancouver

Kumbhare MR, Chandak SM, Dukare AB, Kshatriya VV, Velhal SS. An Updated Comprehensive Review of the Dengue Vaccine: Development, Mechanism, Efficacy, and Safety. Journal of Bio-X Research. 2025;8. doi:10.34133/jbioxresearch.0034

BibTeX
@article{Kumbhare2025,
  author = {Kumbhare, Manoj Ramesh and Chandak, Siddhi M. and Dukare, Aishwarya Balasaheb and Kshatriya, Vaibhavi Vijay and Velhal, Sakshi S.},
  title = {An Updated Comprehensive Review of the Dengue Vaccine: Development, Mechanism, Efficacy, and Safety},
  journal = {Journal of Bio-X Research},
  year = {2025},
  volume = {8},
  doi = {10.34133/jbioxresearch.0034}
}
Kostenlos starten →